The closely watched coronavirus vaccine trial resumed after an independent committee and health regulators investigated a possible adverse event and found it was safe to continue the study.
View original article
Contributor: Carolyn Y. Johnson
The closely watched coronavirus vaccine trial resumed after an independent committee and health regulators investigated a possible adverse event and found it was safe to continue the study.
View original article
Contributor: Carolyn Y. Johnson